Advertisement
Table 3 Demographic data, ASA classification and patient classification categorised according to delay in definitive treatment
| Characteristic | All patients (n = 57) | Definitive treatment not delayed (n = 36) | Definitive treatment delayed (n = 21) | p value |
|---|---|---|---|---|
| Age, mean (SD) | 57.0 (21.9) | 55.5 (21.5) | 59.4 (22.8) | 0.52a |
| Age group, n (%) | 0.36b | |||
| < 18 yrs | 4 (7) | 2 (6) | 2 (10) | |
| 18–65 yrs | 29 (51) | 21 (58) | 8 (38) | |
| > 65 yrs | 24 (42) | 13 (36) | 11 (52) | |
| Gender (male), n (%) | 30 (53) | 18 (50) | 12 (57) | 0.78c |
| ASA classification, n (%) | 0.89b | |||
| ASA I | 15 (26) | 10 (28) | 5 (24) | |
| ASA II | 18 (32) | 10 (28) | 8 (38) | |
| ASA III | 23 (40) | 15 (42) | 8 (38) | |
| ASA IV | 1 (2) | 1 (3) | 0 | |
| Patient classification, n (%) | 0.016c | |||
| Internal medicine | 20 (35) | 10 (28) | 10 (48) | |
| Neurology | 22 (39) | 19 (53) | 3 (14) | |
| Trauma | 15 (26) | 7 (19) | 8 (38) |
